Colour: Sunset yellow fcf EMPACON MET 5/1000 TABLET - Empagliflozin 5 Mg, Metformin Hydrochloride 1000 Mg, Excipients Q.s
According to the company, 85.1 percent of adults on survodutide achieved at least 5 percent weight loss after 76 weeks, versus 38.8 percent on placebo
Gastroparesis, often referred to as stomach paralysis or gastric obstruction, is a medical condition characterized by a significant delay in the movement of food from the stomach to the small intestine
Active or prior cancer BPC-157 promotes angiogenesis in animal models
These issues require careful management, which includes specific dietary guidance, appropriate medication as well as judicious dose adjustments
No change in food intake, emetic events or skin irritation at the injection sites were observed